VMS symptoms and cardiovascular implications
Rebecca Thurston, PhD, sits down to discuss her research presented at the NAMS Annual Meeting on vasomotor symptoms and cardiovascular health.
In an exclusive video interview, Rebecca Thurston, PhD, sits down with Contemporary OB/GYN® Managing Editor Morgan Petronelli to discuss her presentations from the North American Menopause Society's (NAMS) Annual Meeting held recently in Atlanta, Georgia, from October 12-15.
Thurston is the chair of the Pittsburgh Foundation; a professor of psychiatry, psychology, and epidemiology at the University of Pittsburgh where she directs the Women's Behavioral Health program; and is the NAMS 2022 Scientific program chair.
S3E20: Brooke Faught, NP on sexual health, trauma-informed care, and the perks of meeting in-person
December 3rd 2021In this episode of Pap Talk, we took you with us to the North American Menopause Society's recent Annual Meeting. Sexual health specialist Michael Krychman, MD, sat down with Brooke Faught, NP, to learn more about her work at the Women's Institute for Sexual Health, her role on the NAMS Planning Committee, and her tips for talking trauma with patients.
Listen
Elinzanetant's efficacy for vasomotor symptoms confirmed in phase 3 trial
March 19th 2024Bayer's OASIS 3 trial affirmsed the safety and efficacy of elinzanetant in reducing moderate to severe vasomotor symptoms, bolstering confidence in its potential as a non-hormonal solution for menopause-related issues.
Read More
